PULSE: Antithrombotic Strategies after TAVR: To DO(AC) or DON’T
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Target Audience
Pharmacist
Learning Objectives
1. To describe guideline-based recommendation strategies on the use of antithrombotic therapies in patients following TAVR (Transcatheter Aortic Value Replacement)
2. To discuss primary literature related to the safety of the use of antiplatelets and anticoagulant therapy following TAVR
3. To identify appropriate adjunctive Antithrombotic Therapy for Patients with Aortic Stenosis Undergoing TAVR
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Julie DiBridge, PharmD, BCPS
PGY2 Cardiology Resident
UPMC Presbyterian
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.